Peripheral artery disease trials in India

1 trial · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

  Where

  Aligarh, Jaipur, Kolkata, Kozhikode, Nagpur, Nashik, New Delhi, Rishikesh, Surat

  Age

  18 years and over

  People

  1,205 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07223593 · EU 2025-523283-21-00